| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/28/2007 | EP1757289A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
| 02/28/2007 | EP1756041A2 Polycationic compounds and uses thereof |
| 02/28/2007 | EP1755676A1 Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins |
| 02/28/2007 | EP1755630A1 Pharmaceutical compositions from beard lichen (usnea barbata) and st. john's wort (hypericum perforatum) and their use |
| 02/28/2007 | EP1755610A2 Thienopyrimidines and thiazolopyrimidines for use in medicine |
| 02/28/2007 | EP1755604A2 Use of opioid receptor antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin |
| 02/28/2007 | EP1755547A2 Haircare compositions and methods |
| 02/28/2007 | EP1755542A1 Mequinol-based dermatological depigmenting composition |
| 02/28/2007 | EP1755541A2 Pharmaceutical or cosmetic composition comprising mequinol and at least one depigmenting agent |
| 02/28/2007 | EP1656128A4 Treatment for acne vulgaris and method of use |
| 02/28/2007 | EP1572179B1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1482951B8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 02/28/2007 | EP1439832B1 Method of treating acne vulgaris using avermectin compound |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1320541B1 Tgf-beta inhibitors and methods |
| 02/28/2007 | EP1272186B1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | EP1233013B1 Novel phenylalanine derivatives |
| 02/28/2007 | EP1150671B1 Use of pyrethroid compounds to promote hair growth |
| 02/28/2007 | EP1085811B1 Broad specificity dna damage endonuclease |
| 02/28/2007 | EP1079802B1 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention |
| 02/28/2007 | CN1922321A Oligonucleotide and the use thereof for modulating an isoform c beta-1 protein-kinase in the form of a skin depigmentation agent |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921886A Methods of modulating cytokine activity, related reagents |
| 02/28/2007 | CN1921879A Means for stimulation and activation of hair growth by il-15 |
| 02/28/2007 | CN1921873A Coriander oil and preparations which have antimicrobial and antiphlogistic effects and which contain said oil and use thereof |
| 02/28/2007 | CN1921852A Use of metronidazole for preparing a pharmaceutical composition for treating pathologies related to the b-type receptor of interleukin 8 and/or to a pacap type 1 receptor |
| 02/28/2007 | CN1921851A Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous inflammation |
| 02/28/2007 | CN1921850A Use of metronidazole for preparing a pharmaceutical composition for treating a cutaneous vascularisation disorder |
| 02/28/2007 | CN1921847A 氨基醇化合物 Amino alcohol compound |
| 02/28/2007 | CN1921827A Use of a lyophilisate of dedifferentiated plant cells for skin depigmentation and/or lightening |
| 02/28/2007 | CN1919329A Medicine for treating ulcer |
| 02/28/2007 | CN1919291A Decoction medicine for treating verruca acuminata and its preparing process |
| 02/28/2007 | CN1919287A Bee glue capsule |
| 02/28/2007 | CN1919279A Plaster with wind and cold dispelling, toxin removing and clots absorbing function, and its preparing process |
| 02/28/2007 | CN1919274A Stellera chamaejasme injection for treating animal hair tinea disease and its preparation method |
| 02/28/2007 | CN1919260A Tranquilization, stomach nourition, and beauty treatment capsule and its preparation method |
| 02/28/2007 | CN1919209A Pharmaceutical composition for healing skin wound |
| 02/28/2007 | CN1919185A Compound ammonium glycyrrhizinato S dispersed tablet and its preparing process |
| 02/28/2007 | CN1302109C Horny cell growth factor mutant and its preparation method and use thereof |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301973C Heterocyclic derivatives and medicines |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301745C Chinese medicinal liquid for treating alopecia and its production method |
| 02/28/2007 | CN1301736C Poriasis treating Chinese medicine |
| 02/28/2007 | CN1301727C Externally applied Chinese medicine preparation for treating skin disease and its preparation method |
| 02/28/2007 | CN1301719C Quick-acting decoction for treating burns and scald |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/28/2007 | CN1301708C Orally administrable composition for the photoprotection of the skin |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183281 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 02/27/2007 | US7183261 Galactosylceramide analogs, and β-glucocerebrosidase activators, external skin preparations and method of activating β-glucocerebrosidase using the analogs |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183063 Can be used in screening for agents which act as antagonists to MCP-1, MIP-1 alpha and/or RANTES |
| 02/27/2007 | US7182963 Cosmetic and dermopharmaceutical compositions for skin prone to acne |
| 02/22/2007 | WO2007021789A1 Modified green tea polyphenol formulations |
| 02/22/2007 | WO2007020935A1 Therapeutic agent for pain comprising p2y12 receptor and/or p2y14 receptor blocker |
| 02/22/2007 | WO2007020889A1 Novel mucin glycoprotein and use thereof |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020755A1 Agent for hair growth |
| 02/22/2007 | WO2007020286A2 Method of using potassium channel inhibiting compounds |
| 02/22/2007 | WO2007002447A3 Compositions for treating rosacea |
| 02/22/2007 | WO2006134279A3 Method for solubilizing metronidazole |
| 02/22/2007 | US20070043119 Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043079 Heterocyclic compound containing nitrogen atom and use thereof |
| 02/22/2007 | US20070043053 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 02/22/2007 | US20070043051 Methods and compositions of novel triazine compounds |
| 02/22/2007 | US20070043049 Substituted heterocyclic diarylamine analogues |
| 02/22/2007 | US20070043048 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070042997 Medicament for treatment of dermal pigmentation |
| 02/22/2007 | US20070042965 Crystallized structure of type IV collagen NC1 domain hexamer |
| 02/22/2007 | US20070042964 Compositions and methods for modulating connexin hemichannels |
| 02/22/2007 | US20070042963 Therapeutic peptides |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042938 Use of dpiv and apn inhibitors for the treatment of dermatalogical diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts |
| 02/22/2007 | US20070042019 Method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 02/22/2007 | US20070041962 Method of promoting healing of a tympanic membrane perforation |
| 02/22/2007 | US20070041939 Modified cytokines for use in cancer therapy |
| 02/22/2007 | US20070041916 Preparation containing diol |
| 02/22/2007 | US20070041915 Use of a biguanide derivative for protecting skin against uvb radiation |
| 02/22/2007 | US20070041866 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant |
| 02/22/2007 | DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses |
| 02/22/2007 | DE202006019113U1 Vegetable based cream or ointment, useful for the treatment of skin diseases such as psoriasis, comprises Hibiscus species, Saxifraga species, Solidago virgaurea, Salvia officinalis and Opuntia ficus indica |